Company Filing History:
Years Active: 1993
Title: Lorraine Holley: Innovator in Implantable Defibrillation Technology
Introduction
Lorraine Holley is a notable inventor based in Rockdale, Australia. She has made significant contributions to the field of medical technology, particularly in the development of implantable defibrillators. Her innovative work has the potential to save lives by improving the functionality and reliability of these critical devices.
Latest Patents
Lorraine Holley holds a patent for her invention titled "Reconfirmation prior to shock for implantable defibrillation." This multiprogrammable, telemetric implantable defibrillator is designed to revert ventricular tachycardia (VT) and ventricular fibrillation (VF) to normal sinus rhythm. The device features a high-energy shock system and a multi-programmable VVI bradycardia support system. During an automatic shock sequence, the apparatus conducts two points of reconfirmation: at the programmed minimum time to shock and after the full charge has been reached, or at thirty seconds, whichever comes first. Reconfirmation involves testing the tachycardia detection output (TDO). If the TDO is high, reconfirmation occurs. If the TDO is low, reconfirmation will not occur, and the device will subsequently dump the discharge. Two reconfirmations must occur before a shock is delivered to the patient. If the TDO is low at either reconfirmation, the charge will be dumped.
Career Highlights
Lorraine Holley is associated with Telectronics N.V., a company known for its advancements in medical devices. Her work has been instrumental in enhancing the safety and effectiveness of implantable defibrillators, which are crucial for patients at risk of life-threatening arrhythmias.
Collaborations
Some of Lorraine's notable coworkers include Norma L. Gilli and Geoffrey A. Drane. Their collaborative efforts contribute to the innovative environment at Telectronics N.V., fostering advancements in medical technology.
Conclusion
Lorraine Holley's contributions to the field of implantable defibrillation technology exemplify her commitment to improving patient care through innovation. Her patent reflects a significant advancement in medical device technology, showcasing her role as a leading inventor in this critical area.